Assignee
GUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD
CN·9 granted patents·6 pending applications·3 citations·filing 2016–2022
Top patents by PatentIndex Score
15 records- 0184US11078192B2Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereofGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2017·Granted Aug 3, 2021·2 cites·21 claims
- 0267US2022315525A1Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and applicationGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0366US11384048B2Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and applicationGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2018·Granted Jul 12, 2022·0 cites·19 claims
- 0465US10494378B2Fused ring pyrimidine compound, intermediate, and preparation method, composition and use thereofGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2016·Granted Dec 3, 2019·1 cites·18 claims
- 0558US12473300B2Thienopyrimidine derivative and preparation method thereforGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2021·Granted Nov 18, 2025·0 cites·16 claims
- 0657US10611770B2Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereofGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2019·Granted Apr 7, 2020·0 cites·19 claims
- 0756US12428369B2Crystal form of aromatic vinyl derivatives, and preparation method therefor and use thereofGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2021·Granted Sep 30, 2025·0 cites·21 claims
- 0853US10259816B2Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereofGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2016·Granted Apr 16, 2019·0 cites·19 claims
- 0952US2023046904A1Combination of small molecule inhibitor of the pd-1/pd-l1 interaction and anti-pd-1 antibody for treating cancerGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1051US2022313626A1Small molecule inhibitors for treating cancer in a subject having tumors with high interstitial pressureGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1150US2023331675A1Aromatic ethylene compound and preparation method therefor, and intermediate, pharmaceutical composition, and application thereofGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1250US2022168268A1Small-molecule inhibitor of pd-1/pd-l1, pharmaceutical composition thereof with pd-l1 antibody, and application of sameGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1347US11352368B2Salt of fused ring pyrimidine compound, crystal form thereof and preparation method therefor and use thereofGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2019·Granted Jun 7, 2022·0 cites·16 claims
- 1445US2023192653A1Novel Therapeutic MethodsGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1542US11066413B2Aminopyrimidine five-membered heterocyclic compound, and intermediate, preparation method, pharmaceutical composition and application thereofGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2018·Granted Jul 20, 2021·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when GUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →